{
  "response": {
    "status": 200
  },
  "symbol": {
    "id": 11678,
    "symbol": "RARE",
    "title": "Ultragenyx Pharmaceutical",
    "aliases": [],
    "is_following": false,
    "watchlist_count": 1686
  },
  "cursor": {
    "more": true,
    "since": 252761290,
    "max": 252114634
  },
  "messages": [
    {
      "id": 252761290,
      "body": "$NCR ...\ud835\udc04arnings \ud835\udc0flays \ud835\udc13ue pm...\ud835\udc06ainers... \ud83d\udc48\ud83d\udcc5 \ud83d\udc40\ud83d\udc40\ud83d\ude09\ud83d\ude80\ud83d\ude80\ud83d\ude80\ud83d\udc8e\ud83d\udc8e\ud83d\ude80\ud83d\ude80\ud83d\udc4c\ud83d\udd25\ud83d\udd25 \n \n\ud835\udc0d\ud835\udc02\ud835\udc11 \u2191 21.89 (+3.77%) v: 971\ud835\udc0a \ud83d\udcc5 \ud835\udc13ue @ 4:05pm \u2714 \n\ud835\udc13\ud835\udc16\ud835\udc0e\ud835\udc14 \u2191 37.38 (+2.50%) v: 387\ud835\udc0a \ud83d\udcc5 \ud835\udc13ue @ 4:00pm \u2714 \n\ud835\udc02\ud835\udc07\ud835\udc11\ud835\udc16 \u2191 101.17 (+1.59%) v: 518\ud835\udc0a \ud83d\udcc5 \ud835\udc13ue @ 4:15pm \u2714 \n\ud835\udc0c\ud835\udc12\ud835\udc05\ud835\udc13 \u2191 212.90 (+1.34%) v: 12\ud835\udc0c \ud83d\udcc5 \ud835\udc13ue @ 4:10pm \u2714 \n\ud835\udc13\ud835\udc04\ud835\udc0d\ud835\udc01 \u2191 36.94 (+0.93%) v: 306\ud835\udc0a \ud83d\udcc5 \ud835\udc13ue @ 4:05pm \u2714 \n\ud835\udc00\ud835\udc0a\ud835\udc00\ud835\udc0c \u2191 106.60 (+0.51%) v: 783\ud835\udc0a \ud83d\udcc5 \ud835\udc13ue @ 4:00pm \u2714 \n\ud835\udc12\ud835\udc14\ud835\udc0c \u2191 18.86 (+0.16%) v: 403\ud835\udc0a \ud83d\udcc5 \ud835\udc13ue @ 4:20pm \u2714 \n\ud835\udc04\ud835\udc08\ud835\udc17 \u2191 58.24 (+0.09%) v: 558\ud835\udc0a \ud83d\udcc5 \ud835\udc13ue @ 4:05pm \u2714 \n\ud835\udc0e\ud835\udc0a\ud835\udc04 \u2191 29.53 (+0.07%) v: 2\ud835\udc0c \ud83d\udcc5 \ud835\udc13ue @ 4:15pm \u2714 \n\ud835\udc0c\ud835\udc17\ud835\udc08\ud835\udc0c \u2191 71.27 (+0.04%) v: 358\ud835\udc0a \ud83d\udcc5 \ud835\udc13ue @ 4:00pm \u2714 \n\ud835\udc03\ud835\udc04\ud835\udc0d\ud835\udc0d \u2193 10.32 (-0.10%) v: 425\ud835\udc0a \ud83d\udcc5 \ud835\udc13ue @ 5:40pm \u2714 \n\ud835\udc05\ud835\udc08\ud835\udc12\ud835\udc15 \u2193 97.68 (-0.71%) v: 2\ud835\udc0c \ud83d\udcc5 \ud835\udc13ue @ 4:00pm \u2714 \n\ud835\udc02\ud835\udc01 \u2193 125.03 (-0.76%) v: 456\ud835\udc0a \ud83d\udcc5 \ud835\udc13ue @ 4:05pm \u2714 \n\ud835\udc01\ud835\udc06\ud835\udc05\ud835\udc15 \u2193 7.92 (-0.88%) v: 525\ud835\udc0a \ud83d\udcc5 \ud835\udc13ue @ 4:00pm \u2714 \n\ud835\udc05\ud835\udc04\ud835\udc18\ud835\udc04 \u2193 14.03 (-0.88%) v: 1\ud835\udc0c \ud83d\udcc5 \ud835\udc13ue @ 4:00pm \u2714 \n \n$RARE $NCR $KTCC $MASI",
      "created_at": "2020-10-27T16:29:57Z",
      "user": {
        "id": 3832422,
        "username": "jenpennys",
        "name": "Jen",
        "avatar_url": "https://avatars.stocktwits.com/production/3832422/thumb-1597691191.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/3832422/thumb-1597691191.png",
        "join_date": "2020-07-22",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 559,
        "following": 0,
        "ideas": 398,
        "watchlist_stocks_count": 8,
        "like_count": 298,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2269,
        "title": "StockTwits Web",
        "url": "https://stocktwits.com"
      },
      "symbols": [
        {
          "id": 2451,
          "symbol": "KTCC",
          "title": "Key Tronic Corp.",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 179
        },
        {
          "id": 2582,
          "symbol": "MASI",
          "title": "Masimo Corporation",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1255
        },
        {
          "id": 6470,
          "symbol": "NCR",
          "title": "NCR Corp.",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 957
        },
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1685
        }
      ],
      "conversation": {
        "parent_message_id": 252761290,
        "in_reply_to_message_id": null,
        "parent": true,
        "replies": 1
      },
      "mentioned_users": [],
      "entities": {
        "sentiment": {
          "basic": "Bullish"
        }
      }
    },
    {
      "id": 252759266,
      "body": "2020-10-27 16:23:08+00:00 Trade Alerts at website , we have discord too check profile for links.\n$ARE, $CRUS, $LITE, $MANH, $RARE    Moving",
      "created_at": "2020-10-27T16:23:12Z",
      "user": {
        "id": 1511377,
        "username": "YuMiStocks_Trade",
        "name": "YuMIStocksTrade.com",
        "avatar_url": "https://avatars.stocktwits.com/production/1511377/thumb-1596895665.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/1511377/thumb-1596895665.png",
        "join_date": "2018-06-04",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 270,
        "following": 1,
        "ideas": 3250,
        "watchlist_stocks_count": 34,
        "like_count": 599,
        "plus_tier": "month",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 5846,
        "title": "ConfluxBot",
        "url": "https://app.confluxbot.com"
      },
      "symbols": [
        {
          "id": 1458,
          "symbol": "CRUS",
          "title": "Cirrus Logic Inc.",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 4515
        },
        {
          "id": 2578,
          "symbol": "MANH",
          "title": "Manhattan Associates, Inc.",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 522
        },
        {
          "id": 4368,
          "symbol": "ARE",
          "title": "Alexandria Real Estate Equities Inc.",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 361
        },
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1685
        },
        {
          "id": 12898,
          "symbol": "LITE",
          "title": "Lumentum Holdings",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 5057
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 252686829,
      "body": "$RARE (+0.0% pre) Genetx, Ultragenyx report serious adverse event for Angelman syndrome candidate - SA\n\nhttp://ooc.bz/l/62743",
      "created_at": "2020-10-27T11:54:55Z",
      "user": {
        "id": 348830,
        "username": "OpenOutcrier",
        "name": "Open Outcrier",
        "avatar_url": "https://avatars.stocktwits.com/production/348830/thumb-1423676197.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/348830/thumb-1423676197.png",
        "join_date": "2014-04-30",
        "official": false,
        "identity": "User",
        "classification": [
          "suggested"
        ],
        "followers": 193496,
        "following": 139,
        "ideas": 119147,
        "watchlist_stocks_count": 0,
        "like_count": 976,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2384,
        "title": "Open Outcrier",
        "url": "http://openoutcrier.com"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1686
        }
      ],
      "links": [
        {
          "title": "Genetx, Ultragenyx report serious adverse event for Angelman syndrome candidate (NASDAQ:RARE)",
          "url": "http://ooc.bz/l/62743",
          "shortened_url": "http://ooc.bz/l/62743",
          "shortened_expanded_url": "seekingalpha.com/news/36260...",
          "description": "Ultragenyx Pharmaceutical (NASDAQ:RARE) and its collaborating partner , GeneTx Biotherapeutics, have reported interim data from the Phase 1/2 study evaluating GTX-102 in Angelman syndrome.Though according to the interim data from the first five patients treated indicate, substantial improvements in all patients in at least two disease domains including communication, behavior, sleep, gross motor function, and fine motor function as measured by the improvement scale at day 128.",
          "image": "https://static3.seekingalpha.com/assets/og_image_192-59bfd51c9fe6af025b2f9f96c807e46f8e2f06c5ae787b15bf1423e6c676d4db.png",
          "created_at": "2020-10-27T11:54:57Z",
          "video_url": null,
          "source": {
            "name": "Seeking Alpha",
            "website": "https://seekingalpha.com"
          }
        }
      ],
      "likes": {
        "total": 2,
        "user_ids": [
          4129913,
          3079763
        ]
      },
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 252642524,
      "body": "BofA $RARE: Angelman not yet a major part of valuation\n\u2022Interim ph 1/2 results of ASO GTX-102 showed signs of benefits in Angelman syndrome. Visibility is needed on the SAE of lower extremity weakness. We await regulatory feedback and updates on trial resumption near term.  We maintain our Buy with $107 PO, as we look for more color at the 3Q call tomorrow at 5PM ET.",
      "created_at": "2020-10-27T00:24:19Z",
      "user": {
        "id": 1703581,
        "username": "Quantumup",
        "name": "Quantumup",
        "avatar_url": "https://avatars.stocktwits.com/production/1703581/thumb-1557087590.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/1703581/thumb-1557087590.png",
        "join_date": "2018-11-08",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 159,
        "following": 0,
        "ideas": 2387,
        "watchlist_stocks_count": 88,
        "like_count": 196,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2269,
        "title": "StockTwits Web",
        "url": "https://stocktwits.com"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1684
        }
      ],
      "reshares": {
        "reshared_count": 1,
        "user_ids": [
          1703581
        ]
      },
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 252634039,
      "body": "MEPSEVII new trademark application by Ultragenyx Pharmaceutical Inc. https://uspto.report/TM/90271856 #MEPSEVII $RARE",
      "created_at": "2020-10-26T23:17:51Z",
      "user": {
        "id": 2831538,
        "username": "uspto",
        "name": "Trademarkbot",
        "avatar_url": "https://avatars.stocktwits.com/production/2831538/thumb-1569611907.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/2831538/thumb-1569611907.png",
        "join_date": "2019-09-27",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 79,
        "following": 0,
        "ideas": 3343,
        "watchlist_stocks_count": 0,
        "like_count": 130,
        "plus_tier": "month",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 5681,
        "title": "Trademark Reporter",
        "url": "https://uspto.report"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1684
        }
      ],
      "links": [
        {
          "title": "MEPSEVII - Ultragenyx Pharmaceutical Inc. Trademark Registration",
          "url": "https://uspto.report/TM/90271856",
          "shortened_url": "https://uspto.report/TM/90271856",
          "shortened_expanded_url": "uspto.report/TM/90271856",
          "description": "Trademark registration for Ultragenyx Pharmaceutical Inc.. The mark consists of the word MEPSEVII in a stylized font.",
          "image": "https://uspto.report/TM/90271856/mark.png",
          "created_at": "2020-10-26T23:17:52Z",
          "video_url": null,
          "source": {
            "name": "USPTO.report",
            "website": "https://uspto.report"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "chart": {
          "thumb": "https://charts.stocktwits.com/production/small_252634039.",
          "large": "https://charts.stocktwits.com/production/large_252634039.",
          "original": "https://charts.stocktwits.com/production/original_252634039.",
          "url": "https://charts.stocktwits.com/production/original_252634039."
        },
        "sentiment": null
      }
    },
    {
      "id": 252606286,
      "body": "$RARE just filed with the SEC a Financial Exhibit https://last10k.com/sec-filings/rare/0000950170-20-000088.htm?utm_source=stocktwits&amp;utm_medium=forum&amp;utm_campaign=8K&amp;utm_term=rare",
      "created_at": "2020-10-26T20:29:53Z",
      "user": {
        "id": 1409376,
        "username": "Last10K",
        "name": "Last10K.com",
        "avatar_url": "https://avatars.stocktwits.com/production/1409376/thumb-1559672751.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/1409376/thumb-1559672751.png",
        "join_date": "2018-02-13",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 1243,
        "following": 0,
        "ideas": 225647,
        "watchlist_stocks_count": 0,
        "like_count": 352,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 3968,
        "title": "Last10K",
        "url": "https://last10k.com"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1683
        }
      ],
      "links": [
        {
          "title": "Ultragenyx Pharmaceutical Inc. (RARE) 10K Annual Reports & 10Q SEC Filings | Last10K",
          "url": "https://last10k.com/sec-filings/rare/0000950170-20-000088.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=rare",
          "shortened_url": "https://last10k.com/sec-filings/rare/0000950170-20-000088.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=rare",
          "shortened_expanded_url": "last10k.com/sec-filings/rare",
          "description": "Contact Ultragenyx Pharmaceutical Inc. Investors & Media Danielle Keatley 415-475-6876 Ultragenyx Reports Fourth Quarter and Full Year 2019 Financial Results and Corporate Update 2019 total revenue is $103.7 million; 2019 Crysvita\u00ae (burosumab) revenue to Ultragenyx is $87.3 million 2020 Crysvita revenue in Ultragenyx territories guidance of $125 million to $140 million reaffirmed NOVATO, Calif.",
          "image": "https://last10k.com/sec-filings/report/1515673/000156459020004589/gend5dpfnv1u000001.jpg",
          "created_at": "2020-10-26T20:29:55Z",
          "video_url": null,
          "source": {
            "name": "Last10k",
            "website": "https://last10k.com"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 252603076,
      "body": "$RARE GeneTx and Ultragenyx Announce Positive Interim Phase 1/2 Data on Investigational GTX-102 Demonstrating Improvement in Patients with Angelman Syndrome https://www.otcdynamics.com/rare-genetx-and-ultragenyx-announce-positive-interim-phase-1-2-data-on-investigational-gtx-102-demonstrating-improvement-in-patients-with-angelman-syndrome",
      "created_at": "2020-10-26T20:17:40Z",
      "user": {
        "id": 253206,
        "username": "otcdynamics",
        "name": "otcdynamics",
        "avatar_url": "https://avatars.stocktwits.com/production/253206/thumb-1432182723.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/253206/thumb-1432182723.png",
        "join_date": "2013-08-16",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 384,
        "following": 0,
        "ideas": 52153,
        "watchlist_stocks_count": 0,
        "like_count": 55,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 5512,
        "title": "project_n",
        "url": "https://www.otcdynamics.com"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1683
        }
      ],
      "links": [
        {
          "title": "$RARE GeneTx and Ultragenyx Announce Positive Interim Phase 1/2 Data on Investigational GTX-102 Demonstrating Improvement in Patients with Angelman Syndrome",
          "url": "https://www.otcdynamics.com/rare-genetx-and-ultragenyx-announce-positive-interim-phase-1-2-data-on-investigational-gtx-102-demonstrating-improvement-in-patients-with-angelman-syndrome",
          "shortened_url": "https://www.otcdynamics.com/rare-genetx-and-ultragenyx-announce-positive-interim-phase-1-2-data-on-investigational-gtx-102-demonstrating-improvement-in-patients-with-angelman-syndrome",
          "shortened_expanded_url": "otcdynamics.com/rare-genetx...",
          "description": "Efficacy in multiple functional measures observed in all five patients treated Highest doses associated with a significant but reversible safety issue Study amendment planned to focus on lower end of dose range Conference call to discuss results planned for 5pm Eastern Time SARASOTA, Fla. and NOVATO, Calif., Oct.",
          "image": null,
          "created_at": "2020-10-26T20:17:41Z",
          "video_url": null,
          "source": {
            "name": "Otcdynamics",
            "website": "https://www.otcdynamics.com"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 252602625,
      "body": "Ultragenyx Pharmaceutical: Genetx And Ultragenyx Announce Positive Interim Phase 1/2 Data On In http://www.conferencecalltranscripts.org/8/summary2/?id=8475737 $RARE",
      "created_at": "2020-10-26T20:16:03Z",
      "user": {
        "id": 210967,
        "username": "cctranscripts",
        "name": "Conference Call Transcripts",
        "avatar_url": "https://avatars.stocktwits.com/production/210967/thumb-1363372333.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/210967/thumb-1363372333.png",
        "join_date": "2013-01-30",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 6313,
        "following": 9,
        "ideas": 2351713,
        "watchlist_stocks_count": 0,
        "like_count": 755,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 1130,
        "title": "cctranscripts",
        "url": "http://conferencecalltranscripts.org"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1683
        }
      ],
      "links": [
        {
          "title": "Conference Call Transcripts",
          "url": "http://www.conferencecalltranscripts.org/8/summary2/?id=8475737",
          "shortened_url": "http://www.conferencecalltranscripts.org/8/summary2/?id=8475737",
          "shortened_expanded_url": "conferencecalltranscripts.o...",
          "description": "Get notified next time RARE.US makes a similar move! The following excerpt is from the company's SEC filing . Efficacy in multiple functional measures observed in all five patients treated Highest doses associated with a significant but reversible safety issue Study amendment planned to focus on lower end of dose range Conference call to discuss results planned for 5pm Eastern Time SARASOTA, Fla.",
          "image": null,
          "created_at": "2020-10-26T20:16:04Z",
          "video_url": null,
          "source": {
            "name": "Conferencecalltranscripts",
            "website": "http://www.conferencecalltranscripts.org"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 252601393,
      "body": "$RARE [15s. delayed] filed form 8-K on October 26, 16:11:03: Item8.01: Other Material Events https://s.flashalert.me/bl6gbB",
      "created_at": "2020-10-26T20:12:10Z",
      "user": {
        "id": 595702,
        "username": "fla",
        "name": "FlashAlert_me",
        "avatar_url": "https://avatars.stocktwits.com/production/595702/thumb-1550769466.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/595702/thumb-1550769466.png",
        "join_date": "2015-09-09",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 2629,
        "following": 60,
        "ideas": 705290,
        "watchlist_stocks_count": 0,
        "like_count": 4,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 4622,
        "title": "FlashAlert",
        "url": "https://flashalert.me/"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1683
        }
      ],
      "links": [
        {
          "title": "Flash Alert",
          "url": "https://s.flashalert.me/bl6gbB",
          "shortened_url": "https://s.flashalert.me/bl6gbB",
          "shortened_expanded_url": "sec.gov/Archives/edgar/data...",
          "description": "Real-time alerts about equities, ETFs, cryptocurrencies and more sent to any device",
          "image": null,
          "created_at": "2020-10-26T20:12:11Z",
          "video_url": null,
          "source": {
            "name": "Flashalert",
            "website": "https://flashalert.me"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 252599294,
      "body": "$RARE NEW ARTICLE : GeneTx and Ultragenyx Announce Positive Interim Phase 1/2 Data on Investigational GTX-102 Demonstrating Improvement in Patients with Angelman Syndrome https://www.stck.pro/news/RARE/8756461",
      "created_at": "2020-10-26T20:05:30Z",
      "user": {
        "id": 1555408,
        "username": "STCKPRO",
        "name": "STCK.PRO",
        "avatar_url": "https://avatars.stocktwits.com/production/1555408/thumb-1576077822.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/1555408/thumb-1576077822.png",
        "join_date": "2018-07-24",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 4319,
        "following": 2,
        "ideas": 258887,
        "watchlist_stocks_count": 18,
        "like_count": 52,
        "plus_tier": "month",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 5011,
        "title": "STCK.PRO",
        "url": "https://dashboard.stck.pro"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1683
        }
      ],
      "links": [
        {
          "title": "Ultragenyx Pharmaceutical (RARE)",
          "url": "https://www.stck.pro/news/RARE/8756461",
          "shortened_url": "https://www.stck.pro/news/RARE/8756461",
          "shortened_expanded_url": "stck.pro/news/RARE",
          "description": "Never miss an important article again, stay on top of your investments and become a better investor today! Get your moat on and sync your watchlist with Stocktwits and get all the latest news for your symbols. Sync with Stocktwits",
          "image": "https://www.stck.pro/img/imac.png",
          "created_at": "2020-10-26T20:05:35Z",
          "video_url": null,
          "source": {
            "name": "Stck",
            "website": "https://www.stck.pro"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "chart": {
          "thumb": "https://charts.stocktwits.com/production/small_252599294.jpg",
          "large": "https://charts.stocktwits.com/production/large_252599294.jpg",
          "original": "https://charts.stocktwits.com/production/original_252599294.jpg",
          "url": "https://charts.stocktwits.com/production/original_252599294.jpg"
        },
        "sentiment": null
      }
    },
    {
      "id": 252598275,
      "body": "$RARE [15s. delayed]: Issued Press Release on October 26, 16:01:00: GeneTx and Ultragenyx Announce Positive Interim Phase 1/2 Data on Inve https://s.flashalert.me/vCgdL",
      "created_at": "2020-10-26T20:02:24Z",
      "user": {
        "id": 595702,
        "username": "fla",
        "name": "FlashAlert_me",
        "avatar_url": "https://avatars.stocktwits.com/production/595702/thumb-1550769466.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/595702/thumb-1550769466.png",
        "join_date": "2015-09-09",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 2629,
        "following": 60,
        "ideas": 705290,
        "watchlist_stocks_count": 0,
        "like_count": 4,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 4622,
        "title": "FlashAlert",
        "url": "https://flashalert.me/"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1683
        }
      ],
      "links": [
        {
          "title": "Flash Alert",
          "url": "https://s.flashalert.me/vCgdL",
          "shortened_url": "https://s.flashalert.me/vCgdL",
          "shortened_expanded_url": "globenewswire.com/news-rele...",
          "description": "Real-time alerts about equities, ETFs, cryptocurrencies and more sent to any device",
          "image": null,
          "created_at": "2020-10-26T20:02:25Z",
          "video_url": null,
          "source": {
            "name": "Flashalert",
            "website": "https://flashalert.me"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 252583150,
      "body": "Ultragenyx Pharmaceutical Inc. ($RARE) 3Q20 Earnings Sneak Peek\n\nhttps://www.stockmarketintellects.com/wp-admin/admin.php?page=w3tc_dashboard&amp;w3tc_flush_post&amp;post_id=90066&amp;_wpnonce=748d581926",
      "created_at": "2020-10-26T19:04:56Z",
      "user": {
        "id": 2189196,
        "username": "stockmarketintellects",
        "name": "SMI News Alerts",
        "avatar_url": "https://avatars.stocktwits.com/production/2189196/thumb-1593090548.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/2189196/thumb-1593090548.png",
        "join_date": "2019-07-11",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 156,
        "following": 0,
        "ideas": 11593,
        "watchlist_stocks_count": 0,
        "like_count": 0,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2269,
        "title": "StockTwits Web",
        "url": "https://stocktwits.com"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1682
        }
      ],
      "links": [
        {
          "title": "Log In \u2039 Stock Market Intellects - WordPress",
          "url": "https://www.stockmarketintellects.com/wp-admin/admin.php?page=w3tc_dashboard&w3tc_flush_post&post_id=90066&_wpnonce=748d581926",
          "shortened_url": "https://www.stockmarketintellects.com/wp-admin/admin.php?page=w3tc_dashboard&w3tc_flush_post&post_id=90066&_wpnonce=748d581926",
          "shortened_expanded_url": "stockmarketintellects.com/w...",
          "description": null,
          "image": null,
          "created_at": "2020-10-26T19:04:58Z",
          "video_url": null,
          "source": {
            "name": "Stockmarketintellects",
            "website": "https://www.stockmarketintellects.com"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 252567928,
      "body": "$RARE NEW ARTICLE : Ultragenyx Pharmaceutical Q3 Earnings Preview https://www.stck.pro/news/RARE/8754138",
      "created_at": "2020-10-26T18:02:27Z",
      "user": {
        "id": 1555408,
        "username": "STCKPRO",
        "name": "STCK.PRO",
        "avatar_url": "https://avatars.stocktwits.com/production/1555408/thumb-1576077822.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/1555408/thumb-1576077822.png",
        "join_date": "2018-07-24",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 4338,
        "following": 2,
        "ideas": 260434,
        "watchlist_stocks_count": 18,
        "like_count": 52,
        "plus_tier": "month",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 5011,
        "title": "STCK.PRO",
        "url": "https://dashboard.stck.pro"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1686
        }
      ],
      "links": [
        {
          "title": "Ultragenyx Pharmaceutical (RARE)",
          "url": "https://www.stck.pro/news/RARE/8754138",
          "shortened_url": "https://www.stck.pro/news/RARE/8754138",
          "shortened_expanded_url": "stck.pro/news/RARE",
          "description": "Never miss an important article again, stay on top of your investments and become a better investor today! Get your moat on and sync your watchlist with Stocktwits and get all the latest news for your symbols. Sync with Stocktwits",
          "image": "https://www.stck.pro/img/imac.png",
          "created_at": "2020-10-26T18:02:30Z",
          "video_url": null,
          "source": {
            "name": "Stck",
            "website": "https://www.stck.pro"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 252443902,
      "body": "$RARE 10/27 earnings lets see",
      "created_at": "2020-10-26T04:06:38Z",
      "user": {
        "id": 744799,
        "username": "swardzinski",
        "name": "Sue W",
        "avatar_url": "https://avatars.stocktwits.com/production/744799/thumb-1506619270.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/744799/thumb-1506619270.png",
        "join_date": "2016-05-04",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 74,
        "following": 210,
        "ideas": 1684,
        "watchlist_stocks_count": 72,
        "like_count": 6255,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2269,
        "title": "StockTwits Web",
        "url": "https://stocktwits.com"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1684
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 252384777,
      "body": "UltragenyxPharmaceutical $RARE BidaskScore is #Reiterated to Bought https://bidaskclub.com/news/company/2020-10-23/RARE",
      "created_at": "2020-10-25T09:52:03Z",
      "user": {
        "id": 1177001,
        "username": "BidaskBot",
        "name": "BidaskBot",
        "avatar_url": "https://avatars.stocktwits.com/production/1177001/thumb-1504377126.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/1177001/thumb-1504377126.png",
        "join_date": "2017-09-02",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 1031,
        "following": 21,
        "ideas": 66076,
        "watchlist_stocks_count": 20,
        "like_count": 1008,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 3725,
        "title": "BidaskBot",
        "url": "https://bidaskclub.com"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1684
        }
      ],
      "links": [
        {
          "title": "BidaskClub.com - See where people invest",
          "url": "https://bidaskclub.com/news/company/2020-10-23/RARE",
          "shortened_url": "https://bidaskclub.com/news/company/2020-10-23/RARE",
          "shortened_expanded_url": "bidaskclub.com/news/company...",
          "description": "Use the proprietary BidaskScore to see where people invest. Use the market heatmap and market screener to explore the US equity stock market",
          "image": null,
          "created_at": "2020-10-25T09:52:03Z",
          "video_url": null,
          "source": {
            "name": "Bidaskclub",
            "website": "https://bidaskclub.com"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "chart": {
          "thumb": "https://charts.stocktwits.com/production/small_252384777.png",
          "large": "https://charts.stocktwits.com/production/large_252384777.png",
          "original": "https://charts.stocktwits.com/production/original_252384777.png",
          "url": "https://charts.stocktwits.com/production/original_252384777.png"
        },
        "sentiment": null
      }
    },
    {
      "id": 252244888,
      "body": "$SLDB $SAVA $SRNE $RARE Don&#39;t be surprised to see insider buying in SLDB now that the collaboration news with RARE is out.  I expect insiders to be buying at these prices.  STRONG BUY ON SLDB and headed to $10!\n\nSLDB will outperform SAVA, SRNE and RARE short term.",
      "created_at": "2020-10-23T19:34:25Z",
      "user": {
        "id": 615198,
        "username": "Vertical_Capital",
        "name": "John Ellerton",
        "avatar_url": "https://avatars.stocktwits.com/production/615198/thumb-1444749137.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/615198/thumb-1444749137.png",
        "join_date": "2015-10-13",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 142,
        "following": 73,
        "ideas": 1913,
        "watchlist_stocks_count": 80,
        "like_count": 736,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2269,
        "title": "StockTwits Web",
        "url": "https://stocktwits.com"
      },
      "symbols": [
        {
          "id": 3258,
          "symbol": "SAVA",
          "title": "Cassava Sciences Inc",
          "aliases": [
            "PTIE"
          ],
          "is_following": false,
          "watchlist_count": 20319
        },
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1682
        },
        {
          "id": 11709,
          "symbol": "SRNE",
          "title": "Sorrento Therapeutics Inc.",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 60143
        },
        {
          "id": 14372,
          "symbol": "SLDB",
          "title": "Solid Biosciences",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 3692
        }
      ],
      "conversation": {
        "parent_message_id": 252244888,
        "in_reply_to_message_id": null,
        "parent": true,
        "replies": 3
      },
      "likes": {
        "total": 2,
        "user_ids": [
          166026,
          1313054
        ]
      },
      "mentioned_users": [],
      "entities": {
        "chart": {
          "thumb": "https://charts.stocktwits.com/production/small_252244888.png",
          "large": "https://charts.stocktwits.com/production/large_252244888.png",
          "original": "https://charts.stocktwits.com/production/original_252244888.png",
          "url": "https://charts.stocktwits.com/production/original_252244888.png"
        },
        "sentiment": {
          "basic": "Bullish"
        }
      }
    },
    {
      "id": 252182643,
      "body": "BofA ~  $RARE  ~ Expanding gene therapy pipeline into DMD\n\u2022Leveraging its HeLa platform and $SLDB \u2019s mdys construct\n\u2022Several catalysts upcoming from its gene therapy pipeline\nMaintains Buy Rating - $107 PT\n\n$pfe $srpt",
      "created_at": "2020-10-23T15:51:39Z",
      "user": {
        "id": 1703581,
        "username": "Quantumup",
        "name": "Quantumup",
        "avatar_url": "https://avatars.stocktwits.com/production/1703581/thumb-1557087590.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/1703581/thumb-1557087590.png",
        "join_date": "2018-11-08",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 160,
        "following": 0,
        "ideas": 2390,
        "watchlist_stocks_count": 88,
        "like_count": 196,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2269,
        "title": "StockTwits Web",
        "url": "https://stocktwits.com"
      },
      "symbols": [
        {
          "id": 6728,
          "symbol": "PFE",
          "title": "Pfizer Inc.",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 36908
        },
        {
          "id": 11285,
          "symbol": "SRPT",
          "title": "Sarepta Therapeutics Inc.",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 13610
        },
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1685
        },
        {
          "id": 14372,
          "symbol": "SLDB",
          "title": "Solid Biosciences",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 3686
        }
      ],
      "mentioned_users": [],
      "entities": {
        "chart": {
          "thumb": "https://charts.stocktwits.com/production/small_252182643.png",
          "large": "https://charts.stocktwits.com/production/large_252182643.png",
          "original": "https://charts.stocktwits.com/production/original_252182643.png",
          "url": "https://charts.stocktwits.com/production/original_252182643.png"
        },
        "sentiment": null
      }
    },
    {
      "id": 252130110,
      "body": "$RARE and $SLDB Announce Strategic Collaboration to Develop and Commercialize New Gene Therapies for Duchenne Muscular Dystrophy",
      "created_at": "2020-10-23T13:21:52Z",
      "user": {
        "id": 1335391,
        "username": "YGLD",
        "name": "YGLD",
        "avatar_url": "https://avatars.stocktwits.com/production/1335391/thumb-1578061879.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/1335391/thumb-1578061879.png",
        "join_date": "2017-12-26",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 6303,
        "following": 1,
        "ideas": 11845,
        "watchlist_stocks_count": 0,
        "like_count": 5375,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 1149,
        "title": "StockTwits for iOS",
        "url": "http://www.stocktwits.com/mobile"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1684
        },
        {
          "id": 14372,
          "symbol": "SLDB",
          "title": "Solid Biosciences",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 3686
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 252129036,
      "body": "$SLDB $RARE  \n \n2 ways for one company to get access to future biotech product from another company: \n- pay cash, get the drug. $JNJ paid like $700M to $XBIT for a drug, as an example \n- pay cash AND get stock. RARE did this w/ SLDB \n \nOnly thing interesting is that the price is of the stock bought is like $5/share \n \nThen what happens?  SLDB keeps working on bringing the drug to market.  If I owned, id sell some or all.  I wouldn&#39;t buy the stock. \n \nTime to bookmark this plan and see what happens over the next couple weeks \n \nSLDB is at $4.02 right now in pre-market",
      "created_at": "2020-10-23T13:17:34Z",
      "user": {
        "id": 992090,
        "username": "TI7812",
        "name": "TI7812 Love My Typos",
        "avatar_url": "https://avatars.stocktwits.com/production/992090/thumb-1597441782.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/992090/thumb-1597441782.png",
        "join_date": "2017-03-11",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 173,
        "following": 28,
        "ideas": 8039,
        "watchlist_stocks_count": 38,
        "like_count": 223,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2269,
        "title": "StockTwits Web",
        "url": "https://stocktwits.com"
      },
      "symbols": [
        {
          "id": 6011,
          "symbol": "JNJ",
          "title": "Johnson & Johnson",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 33344
        },
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1685
        },
        {
          "id": 12527,
          "symbol": "XBIT",
          "title": "Xbiotech",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 2798
        },
        {
          "id": 14372,
          "symbol": "SLDB",
          "title": "Solid Biosciences",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 3686
        }
      ],
      "likes": {
        "total": 1,
        "user_ids": [
          3521675
        ]
      },
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 252128770,
      "body": "PM mOOvers\ud83d\udc40\n\n$MDGS - Medigus: ScoutCam Announces Success of HD Micro Video Camera in NASA&#39;s Robotic Refueling Mission 3\n\n$SCKT - Socket Mobile up 76% on Q3 jump in profitability\n\n$RARE, $SLDB - Ultragenyx And Solid Biosciences Announce Strategic Collaboration To Develop And Commercialize New Gene Therapies For Duchenne Muscular Dystrophy; Solid To Receive $40M Upfront Via Equity Investment And Up To $255M In Milestones Plus Royalty Payments\n\n$DOGZ -Dogness Announces Strategic Partnership with Huayuan Pet and Chongai Trading",
      "created_at": "2020-10-23T13:16:26Z",
      "user": {
        "id": 1084932,
        "username": "MakingDreamsReality",
        "name": "Robert Ferroni",
        "avatar_url": "https://avatars.stocktwits.com/production/1084932/thumb-1523989647.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/1084932/thumb-1523989647.png",
        "join_date": "2017-06-08",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 3101,
        "following": 14,
        "ideas": 2614,
        "watchlist_stocks_count": 172,
        "like_count": 409,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2269,
        "title": "StockTwits Web",
        "url": "https://stocktwits.com"
      },
      "symbols": [
        {
          "id": 3472,
          "symbol": "SCKT",
          "title": "Socket Mobile, Inc.",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 2325
        },
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1684
        },
        {
          "id": 13151,
          "symbol": "MDGS",
          "title": "Medigus Ltd.",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 5786
        },
        {
          "id": 14021,
          "symbol": "DOGZ",
          "title": "Dogness Intl Corp",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 611
        },
        {
          "id": 14372,
          "symbol": "SLDB",
          "title": "Solid Biosciences",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 3686
        }
      ],
      "likes": {
        "total": 1,
        "user_ids": [
          4184528
        ]
      },
      "mentioned_users": [],
      "entities": {
        "sentiment": {
          "basic": "Bullish"
        }
      }
    },
    {
      "id": 252127895,
      "body": "$SLDB Seem to be a lot of scare tactics being posted this morning. Hmmm. I guess if I were short a sub $200 million market cap company like this, and it just got a big vote of confidence from $6 billion market cap $RARE. . . buying stock at a 33% premium to market. . . I might be nervous too.",
      "created_at": "2020-10-23T13:13:18Z",
      "user": {
        "id": 3521675,
        "username": "BrookTrout",
        "name": "BrookTrout",
        "avatar_url": "http://avatars.stocktwits.com/images/default_avatar_thumb.jpg",
        "avatar_url_ssl": "https://s3.amazonaws.com/st-avatars/images/default_avatar_thumb.jpg",
        "join_date": "2020-05-29",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 9,
        "following": 7,
        "ideas": 256,
        "watchlist_stocks_count": 30,
        "like_count": 119,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2269,
        "title": "StockTwits Web",
        "url": "https://stocktwits.com"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1686
        },
        {
          "id": 14372,
          "symbol": "SLDB",
          "title": "Solid Biosciences",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 3686
        }
      ],
      "likes": {
        "total": 7,
        "user_ids": [
          1535306,
          2873945,
          166026,
          1987721,
          4125645,
          4157538,
          1437654
        ]
      },
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 252122599,
      "body": "$RARE: Ultragenyx and Solid Biosciences Announce Strategic Collaboration to Develop and Commercialize New Gene The ... https://www.chartmill.com/stock/quote/RARE/news?utm_source=stocktwits&amp;utm_medium=pressRelease&amp;utm_content=RARE&amp;utm_campaign=social_tracking",
      "created_at": "2020-10-23T12:48:00Z",
      "user": {
        "id": 47688,
        "username": "ChartMill",
        "name": "ChartMill",
        "avatar_url": "https://avatars.stocktwits.com/production/47688/thumb-1363343728.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/47688/thumb-1363343728.png",
        "join_date": "2011-01-26",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 21947,
        "following": 891,
        "ideas": 1087170,
        "watchlist_stocks_count": 20,
        "like_count": 32,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 1135,
        "title": "ChartMill",
        "url": "http://www.chartmill.com"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1684
        }
      ],
      "links": [
        {
          "title": null,
          "url": "https://www.chartmill.com/stock/quote/RARE/news?utm_source=stocktwits&utm_medium=pressRelease&utm_content=RARE&utm_campaign=social_tracking",
          "shortened_url": "https://www.chartmill.com/stock/quote/RARE/news?utm_source=stocktwits&utm_medium=pressRelease&utm_content=RARE&utm_campaign=social_tracking",
          "shortened_expanded_url": "chartmill.com/stock/quote/R...",
          "description": null,
          "image": null,
          "created_at": "2020-10-23T12:48:00Z",
          "video_url": null,
          "source": {
            "name": "Chartmill",
            "website": "https://www.chartmill.com"
          }
        }
      ],
      "likes": {
        "total": 2,
        "user_ids": [
          4125621,
          4125645
        ]
      },
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 252117827,
      "body": "StockTwits Trending Alert: Trading recent interest in ULTRAGENYX PHARMACEUTICAL INC. $RARE https://wp.me/p5bLGB-bd7D",
      "created_at": "2020-10-23T12:22:55Z",
      "user": {
        "id": 403382,
        "username": "quantcha",
        "name": "Quantcha",
        "avatar_url": "https://avatars.stocktwits.com/production/403382/thumb-1411503795.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/403382/thumb-1411503795.png",
        "join_date": "2014-09-23",
        "official": true,
        "identity": "Official",
        "classification": [
          "official"
        ],
        "followers": 42681,
        "following": 34,
        "ideas": 69822,
        "watchlist_stocks_count": 0,
        "like_count": 13,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 1788,
        "title": "Quantcha Ideas",
        "url": "http://ideas.quantcha.com"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1684
        }
      ],
      "links": [
        {
          "title": "StockTwits Trending Alert: Trading recent interest in ULTRAGENYX PHARMACEUTICAL INC. $RARE",
          "url": "https://wp.me/p5bLGB-bd7D",
          "shortened_url": "https://wp.me/p5bLGB-bd7D",
          "shortened_expanded_url": "ideas.quantcha.com/2020/10/...",
          "description": "Quantcha now offering unlimited commission-free options trading. Quantchabot has detected a promising Bull Call Spread trade opportunity for ULTRAGENYX PHARMACEUTICAL INC. ( RARE) for the 20-Nov-2020 expiration period. You can analyze the opportunity in depth over at the Quantcha Options Search Engine. RARE was recently trading at $91.90 and has an implied volatility of 66.08% for this period.",
          "image": "https://i1.wp.com/ideas.quantcha.com/wp-content/uploads/2020/10/automated-1095.png?fit=1200%2C630&ssl=1",
          "created_at": "2020-10-23T12:23:00Z",
          "video_url": null,
          "source": {
            "name": "Quantcha Trade Ideas",
            "website": "https://ideas.quantcha.com"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "chart": {
          "thumb": "https://charts.stocktwits.com/production/small_252117827.",
          "large": "https://charts.stocktwits.com/production/large_252117827.",
          "original": "https://charts.stocktwits.com/production/original_252117827.",
          "url": "https://charts.stocktwits.com/production/original_252117827."
        },
        "sentiment": null
      }
    },
    {
      "id": 252117764,
      "body": "StockTwits Trending Alert: Trading recent interest in ULTRAGENYX PHARMACEUTICAL INC. $RARE https://wp.me/p5bLGB-bd79",
      "created_at": "2020-10-23T12:22:31Z",
      "user": {
        "id": 403382,
        "username": "quantcha",
        "name": "Quantcha",
        "avatar_url": "https://avatars.stocktwits.com/production/403382/thumb-1411503795.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/403382/thumb-1411503795.png",
        "join_date": "2014-09-23",
        "official": true,
        "identity": "Official",
        "classification": [
          "official"
        ],
        "followers": 42681,
        "following": 34,
        "ideas": 69822,
        "watchlist_stocks_count": 0,
        "like_count": 13,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 1788,
        "title": "Quantcha Ideas",
        "url": "http://ideas.quantcha.com"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1684
        }
      ],
      "links": [
        {
          "title": "StockTwits Trending Alert: Trading recent interest in ULTRAGENYX PHARMACEUTICAL INC. $RARE",
          "url": "https://wp.me/p5bLGB-bd79",
          "shortened_url": "https://wp.me/p5bLGB-bd79",
          "shortened_expanded_url": "ideas.quantcha.com/2020/10/...",
          "description": "Quantcha now offering unlimited commission-free options trading. Quantchabot has detected a promising Bull Call Spread trade opportunity for ULTRAGENYX PHARMACEUTICAL INC. ( RARE) for the 20-Nov-2020 expiration period. You can analyze the opportunity in depth over at the Quantcha Options Search Engine. RARE was recently trading at $91.90 and has an implied volatility of 66.08% for this period.",
          "image": "https://i1.wp.com/ideas.quantcha.com/wp-content/uploads/2020/10/automated-1094.png?fit=1200%2C630&ssl=1",
          "created_at": "2020-10-23T12:22:33Z",
          "video_url": null,
          "source": {
            "name": "Quantcha Trade Ideas",
            "website": "https://ideas.quantcha.com"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "chart": {
          "thumb": "https://charts.stocktwits.com/production/small_252117764.",
          "large": "https://charts.stocktwits.com/production/large_252117764.",
          "original": "https://charts.stocktwits.com/production/original_252117764.",
          "url": "https://charts.stocktwits.com/production/original_252117764."
        },
        "sentiment": null
      }
    },
    {
      "id": 252117471,
      "body": "$RARE just filed with the SEC a Financial Exhibit https://last10k.com/sec-filings/rare/0000950170-20-000085.htm?utm_source=stocktwits&amp;utm_medium=forum&amp;utm_campaign=8K&amp;utm_term=rare",
      "created_at": "2020-10-23T12:20:44Z",
      "user": {
        "id": 1409376,
        "username": "Last10K",
        "name": "Last10K.com",
        "avatar_url": "https://avatars.stocktwits.com/production/1409376/thumb-1559672751.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/1409376/thumb-1559672751.png",
        "join_date": "2018-02-13",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 1243,
        "following": 0,
        "ideas": 225938,
        "watchlist_stocks_count": 0,
        "like_count": 352,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 3968,
        "title": "Last10K",
        "url": "https://last10k.com"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1684
        }
      ],
      "links": [
        {
          "title": "Ultragenyx Pharmaceutical Inc. (RARE) 10K Annual Reports & 10Q SEC Filings | Last10K",
          "url": "https://last10k.com/sec-filings/rare/0000950170-20-000085.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=rare",
          "shortened_url": "https://last10k.com/sec-filings/rare/0000950170-20-000085.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=rare",
          "shortened_expanded_url": "last10k.com/sec-filings/rare",
          "description": "Contact Ultragenyx Pharmaceutical Inc. Investors & Media Danielle Keatley 415-475-6876 Ultragenyx Reports Fourth Quarter and Full Year 2019 Financial Results and Corporate Update 2019 total revenue is $103.7 million; 2019 Crysvita\u00ae (burosumab) revenue to Ultragenyx is $87.3 million 2020 Crysvita revenue in Ultragenyx territories guidance of $125 million to $140 million reaffirmed NOVATO, Calif.",
          "image": "https://last10k.com/sec-filings/report/1515673/000156459020004589/gend5dpfnv1u000001.jpg",
          "created_at": "2020-10-23T12:20:47Z",
          "video_url": null,
          "source": {
            "name": "Last10k",
            "website": "https://last10k.com"
          }
        }
      ],
      "likes": {
        "total": 1,
        "user_ids": [
          4125621
        ]
      },
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 252117077,
      "body": "Ultragenyx Pharmaceutical: Ultragenyx And Solid Biosciences Announce Strategic Collaboration To http://www.conferencecalltranscripts.org/8/summary/?id=8469475 $RARE",
      "created_at": "2020-10-23T12:18:21Z",
      "user": {
        "id": 210967,
        "username": "cctranscripts",
        "name": "Conference Call Transcripts",
        "avatar_url": "https://avatars.stocktwits.com/production/210967/thumb-1363372333.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/210967/thumb-1363372333.png",
        "join_date": "2013-01-30",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 6320,
        "following": 10,
        "ideas": 2353009,
        "watchlist_stocks_count": 0,
        "like_count": 756,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 1130,
        "title": "cctranscripts",
        "url": "http://conferencecalltranscripts.org"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1684
        }
      ],
      "links": [
        {
          "title": "Conference Call Transcripts",
          "url": "http://www.conferencecalltranscripts.org/8/summary/?id=8469475",
          "shortened_url": "http://www.conferencecalltranscripts.org/8/summary/?id=8469475",
          "shortened_expanded_url": "conferencecalltranscripts.o...",
          "description": "Get notified next time RARE.US makes a similar move! The following excerpt is from the company's SEC filing . -Collaboration combines Solid's differentiated microdystrophin construct and Ultragenyx's HeLa PCL manufacturing platform for use with AAV8 and variants- -Solid receives $40 million upfront via equity investment at a premium; up to $255 million in milestones plus royalty payments- -Solid retains exclusive rights to all other uses of its microdystrophins, including its existing SGT-001 program- Novato, Calif.",
          "image": null,
          "created_at": "2020-10-23T12:18:27Z",
          "video_url": null,
          "source": {
            "name": "Conferencecalltranscripts",
            "website": "http://www.conferencecalltranscripts.org"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 252116862,
      "body": "$RARE [15s. delayed] filed form 8-K on October 23, 08:16:08: Item8.01: Other Material Events https://s.flashalert.me/5d7d4",
      "created_at": "2020-10-23T12:17:04Z",
      "user": {
        "id": 595702,
        "username": "fla",
        "name": "FlashAlert_me",
        "avatar_url": "https://avatars.stocktwits.com/production/595702/thumb-1550769466.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/595702/thumb-1550769466.png",
        "join_date": "2015-09-09",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 2636,
        "following": 60,
        "ideas": 706537,
        "watchlist_stocks_count": 0,
        "like_count": 4,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 4622,
        "title": "FlashAlert",
        "url": "https://flashalert.me/"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1684
        }
      ],
      "links": [
        {
          "title": "Flash Alert",
          "url": "https://s.flashalert.me/5d7d4",
          "shortened_url": "https://s.flashalert.me/5d7d4",
          "shortened_expanded_url": "sec.gov/Archives/edgar/data...",
          "description": "Real-time alerts about equities, ETFs, cryptocurrencies and more sent to any device",
          "image": null,
          "created_at": "2020-10-23T12:17:05Z",
          "video_url": null,
          "source": {
            "name": "Flashalert",
            "website": "https://flashalert.me"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 252114981,
      "body": "$RARE NEW ARTICLE : Ultragenyx and Solid Biosciences Announce Strategic Collaboration to Develop and Commercialize New Gene Therapies for Duchenne Muscular Dystrophy https://www.stck.pro/news/RARE/8672749",
      "created_at": "2020-10-23T12:06:34Z",
      "user": {
        "id": 1555408,
        "username": "STCKPRO",
        "name": "STCK.PRO",
        "avatar_url": "https://avatars.stocktwits.com/production/1555408/thumb-1576077822.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/1555408/thumb-1576077822.png",
        "join_date": "2018-07-24",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 4328,
        "following": 2,
        "ideas": 259610,
        "watchlist_stocks_count": 18,
        "like_count": 52,
        "plus_tier": "month",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 5011,
        "title": "STCK.PRO",
        "url": "https://dashboard.stck.pro"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1684
        }
      ],
      "links": [
        {
          "title": "Ultragenyx Pharmaceutical (RARE)",
          "url": "https://www.stck.pro/news/RARE/8672749",
          "shortened_url": "https://www.stck.pro/news/RARE/8672749",
          "shortened_expanded_url": "stck.pro/news/RARE",
          "description": "Never miss an important article again, stay on top of your investments and become a better investor today! Get your moat on and sync your watchlist with Stocktwits and get all the latest news for your symbols. Sync with Stocktwits",
          "image": "https://www.stck.pro/img/imac.png",
          "created_at": "2020-10-23T12:06:46Z",
          "video_url": null,
          "source": {
            "name": "Stck",
            "website": "https://www.stck.pro"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "chart": {
          "thumb": "https://charts.stocktwits.com/production/small_252114981.jpg",
          "large": "https://charts.stocktwits.com/production/large_252114981.jpg",
          "original": "https://charts.stocktwits.com/production/original_252114981.jpg",
          "url": "https://charts.stocktwits.com/production/original_252114981.jpg"
        },
        "sentiment": null
      }
    },
    {
      "id": 252114958,
      "body": "Ultragenyx and Solid Biosciences Announce Strategic Collaboration to Develop and Commercialize New Gene Therapies for Duchenne Muscular Dystrophy http://www.conferencecalltranscripts.org/summary/?id=76706&amp;pr=true $RARE",
      "created_at": "2020-10-23T12:06:25Z",
      "user": {
        "id": 210967,
        "username": "cctranscripts",
        "name": "Conference Call Transcripts",
        "avatar_url": "https://avatars.stocktwits.com/production/210967/thumb-1363372333.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/210967/thumb-1363372333.png",
        "join_date": "2013-01-30",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 6318,
        "following": 10,
        "ideas": 2352801,
        "watchlist_stocks_count": 0,
        "like_count": 756,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 1130,
        "title": "cctranscripts",
        "url": "http://conferencecalltranscripts.org"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1684
        }
      ],
      "links": [
        {
          "title": "Conference Call Transcripts",
          "url": "http://www.conferencecalltranscripts.org/summary/?id=76706&pr=true",
          "shortened_url": "http://www.conferencecalltranscripts.org/summary/?id=76706&pr=true",
          "shortened_expanded_url": "conferencecalltranscripts.o...",
          "description": "Company Conference Call Transcripts",
          "image": null,
          "created_at": "2020-10-23T12:06:26Z",
          "video_url": null,
          "source": {
            "name": "Conferencecalltranscripts",
            "website": "http://www.conferencecalltranscripts.org"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 252114634,
      "body": "$SLDB (+34.1% pre) Ultragenyx $RARE, Solid Biosciences (SLDB) Announce Strategic Collaboration to Develop and Commercialize New Gene Therapies for DMD - SI\n\nhttp://ooc.bz/l/62585",
      "created_at": "2020-10-23T12:04:36Z",
      "user": {
        "id": 348830,
        "username": "OpenOutcrier",
        "name": "Open Outcrier",
        "avatar_url": "https://avatars.stocktwits.com/production/348830/thumb-1423676197.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/348830/thumb-1423676197.png",
        "join_date": "2014-04-30",
        "official": false,
        "identity": "User",
        "classification": [
          "suggested"
        ],
        "followers": 193494,
        "following": 139,
        "ideas": 119146,
        "watchlist_stocks_count": 0,
        "like_count": 976,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2384,
        "title": "Open Outcrier",
        "url": "http://openoutcrier.com"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1684
        },
        {
          "id": 14372,
          "symbol": "SLDB",
          "title": "Solid Biosciences",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 3686
        }
      ],
      "links": [
        {
          "title": null,
          "url": "http://ooc.bz/l/62585",
          "shortened_url": "http://ooc.bz/l/62585",
          "shortened_expanded_url": "streetinsider.com/Corporate...",
          "description": null,
          "image": null,
          "created_at": "2020-10-23T12:04:38Z",
          "video_url": null,
          "source": {
            "name": "Streetinsider",
            "website": "https://www.streetinsider.com"
          }
        }
      ],
      "likes": {
        "total": 2,
        "user_ids": [
          4211297,
          10041
        ]
      },
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    }
  ]
}